International Trade Today is a service of Warren Communications News.
Subscriber Login

EAPA Litigation

Under the Enforce and Protect Act, CBP investigates whether a company is evading particular antidumping and countervailing duty orders. Litigation on determinations made under the relatively new statute have centered on due process protections for respondents, CBP's evidentiary basis for its decisions and the interplay of decisions made on the scope of the applicable AD/CVD orders from both CBP and the Commerce Department. The Court of Appeals for the Federal Circuit issued a key decision for all EAPA cases in Royal Brush Manufacturing v. United States, when it found CBP to have violated a respondent's due process protections by failing to provide it with access to the business proprietary information used in the proceeding. 

to
Refine Category Search
Clear Terms

Search Primer

Multi-word term: Place inside quotes to ensure an exact match together (e.g. "China import").

Term list: Separate terms with spaces, not commas or semicolons to find either word (e.g. AD/CVD antidumping).

Acronyms: Use all capital letters (e.g., ACE).

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., CBP +releases).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., -ruling).

Singular form: Use the singular form when doing multi-word terms (e.g. "russian export control" instead of "russian export controls").

Shortest word form: When you have different word forms in a quoted term, include the shortest version if it is the last part of the expression (e.g., "entity list" instead of "entity listing" or "entity listed").

FDA Plans to Move Up Approval Enforcement Dates for Flavored e-Cigarettes, Cigars
March 14, 2019 |FDA

The Food and Drug Administration intends to move up enforcement dates for new rules on e-cigarettes and flavored cigars in response to concerns about their use among minors, FDA said in a draft guidance issued March 13. Under the proposed policy, FDA would begin requiring pre-marketing approvals for certain e-cigarettes and flavored cigars before they are sold in the U.S., it said. The policy would take effect 30 days after the agency’s guidance is finalized. Comments on the policy are due April 15.

FDA Lifts Import Ban on Genetically Engineered Salmon
March 11, 2019 |FDA

The Food and Drug Administration on March 8 ended a ban on imports of genetically engineered salmon, deactivating Import Alert 99-40 to allow the sale and importation of AquaBounty Technologies’ AquAdvantage Salmon, the only currently approved GE salmon for food use, it said in a “questions and answers” page recently added to the FDA website. The move follows regulations recently issued by the Agricultural Marketing Service setting disclosure requirements for GE foods and set to take effect in 2022 (see 1812260052). Congress had in 2016 directed FDA to ban imports of GE salmon until a labeling standard was developed, a requirement FDA deemed satisfied with the issuance of USDA’s final rule. “FDA intends to revise” agency guidance for “food manufacturers who wish to voluntarily label their food products or ingredients (for humans or animals) derived from Atlantic salmon as not containing GE Atlantic salmon,” it said.